Condition
Cardiovascular Event
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06014112Not ApplicableRecruiting
Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
NCT03590223CompletedPrimary
Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c)
NCT01366599Completed
CV Events in Emetogenic Chemotherapy
NCT01545856CompletedPrimary
Cardiovascular Events in Parkinson's Disease Patients
NCT01152892Unknown
Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study
Showing all 5 trials